Search

Your search keyword '"Valent, Alexander"' showing total 206 results
Start Over Author "Valent, Alexander"
206 results on '"Valent, Alexander"'

1. Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France

Author

Franchet, Camille, Djerroudi, Lounes, Maran-Gonzalez, Aurélie, Abramovici, Olivia, Antoine, Martine, Becette, Véronique, Berghian, Anca, Blanc-Fournier, Cécile, Brabencova, Eva, Charafe-Jauffret, Emmanuelle, Chenard, Marie-Pierre, Dauplat, Marie-Mélanie, Delrée, Paul, Duprez-Paumier, Raphaëlle, Fleury, Clémence, Ghnassia, Jean-Pierre, Haudebourg, Juliette, Leroux, Agnès, MacGrogan, Gaëtan, Mathieu, Marie-Christine, Michenet, Patrick, Penault-Llorca, Frédérique, Poulet, Bruno, Robin, Yves Marie, Roger, Pascal, Russ, Elisabeth, Tixier, Lucie, Treilleux, Isabelle, Valent, Alexander, Verriele, Véronique, Vincent-Salomon, Anne, Arnould, Laurent, and Lacroix-Triki, Magali

Published
2021
Full Text
View/download PDF

2. Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2–14)

Author

Penault-Llorca, Frédérique, Kwiatkowski, Fabrice, Arnaud, Antoine, Levy, Christelle, Leheurteur, Marianne, Uwer, Lionel, Derbel, Olfa, Le Rol, Annick, Jacquin, Jean-Philippe, Jouannaud, Christelle, Quenel-Tueux, Nathalie, Girre, Véronique, Foa, Cyril, Guardiola, Emmanuel, Lortholary, Alain, Catala, Stéphanie, Guiu, Séverine, Valent, Alexander, Boinon, Diane, Lemonnier, Jérome, and Delaloge, Suzette

Published
2020
Full Text
View/download PDF

3. Recommandations du GEFPICS pour la prise en charge des prélèvements dans le cadre du traitement néoadjuvant du cancer du sein

Author

Maran-Gonzalez, Aurélie, Franchet, Camille, Duprez-Paumier, Raphaëlle, Antoine, Martine, Barlier, Catherine, Becette, Véronique, Berghian, Anca, Blanc-Fournier, Cécile, Brabencova, Eva, Charafe-Jauffret, Emmanuelle, Chenard, Marie-Pierre, Dauplat, Marie-Mélanie, Delrée, Paul, Fleury, Clémence, Garbar, Christian, Ghnassia, Jean-Pierre, Haudebourg, Juliette, MacGrogan, Gaëtan, Mathieu, Marie-Christine, Michenet, Patrick, Penault-Llorca, Frédérique, Poulet, Bruno, Robin, Yves, Roger, Pascal, Russ, Elisabeth, Treilleux, Isabelle, Valent, Alexander, Verriele, Véronique, Vincent-Salomon, Anne, Arnould, Laurent, and Lacroix-Triki, Magali

Published
2019
Full Text
View/download PDF

5. Supplementary Table 2 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table 3 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table 4 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

11. Legends to Supplementaries from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Data 2 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

13. Prevalence and characteristics of gonadoblastoma in a retrospective multi-center study with follow-up investigations of 70 patients with Turner syndrome and a 45,X/46,XY karyotype

Author

Karila, Daphné, primary, Donadille, Bruno, additional, Léger, Juliane, additional, Bouvattier, Claire, additional, Bachelot, Anne, additional, Kerlan, Veronique, additional, Catteau-Jonard, Sophie, additional, Salenave, Sylvie, additional, Albarel, Frédérique, additional, Briet, Claire, additional, Coutant, Regis, additional, Brac De La Perriere, Aude, additional, Valent, Alexander, additional, Siffroi, Jean-Pierre, additional, and Christin-Maitre, Sophie, additional

Published
2022
Full Text
View/download PDF

16. Aortic Tissue Analysis in Turner Syndrome

Author

Donadille, Bruno, primary, Valent, Alexander, additional, Amemiya, Kisaki, additional, Rive le Gouard, Nicolas, additional, Iserin, Laurence, additional, Achouh, Paul, additional, Lecot-Connan, Tatiana, additional, Bruneval, Patrick, additional, Siffroi, Jean-Pierre, additional, and Christin-Maitre, Sophie, additional

Published
2022
Full Text
View/download PDF

17. Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France

Author

Penault-Llorca, Frédérique, Vincent-Salomon, Anne, MacGrogan, Gaëtan, Roger, Pascal, Treilleux, Isabelle, Valent, Alexander, Mathieu, Marie-Christine, Antoine, Martine, Becette, Véronique, Bor, Catherine, Brabencova, Eva, Charafe-Jauffret, Emmanuelle, Chenard, Marie-Pierre, Dauplat, Marie-Mélanie, Delrée, Paul, Devouassoux, Mojgan, Fiche, Maryse, Fondrevelle, Marie-Eve, Fridman, Viviana, Garbar, Christian, Genin, Pascal, Ghnassia, Jean-Pierre, Haudebourg, Juliette, Laberge-Le Couteulx, Sophie, Loussouarn, Delphine, Maran-Gonzalez, Aurélie, Marcy, Myriam, Michenet, Patrick, Poulet, Bruno, Sagan, Christine, Trassard, Martine, Verriele, Véronique, Arnould, Laurent, and Lacroix-Triki, Magali

Published
2014
Full Text
View/download PDF

18. Recommandations du GEFPICS concernant la phase pré-analytique pour l’évaluation de HER2 et des récepteurs hormonaux dans le cancer du sein : mise à jour 2014

Author

MacGrogan, Gaëtan, Mathieu, Marie-Christine, Poulet, Bruno, Penault-Llorca, Frédérique, Vincent-Salomon, Anne, Roger, Pascal, Treilleux, Isabelle, Valent, Alexander, Antoine, Martine, Becette, Véronique, Bor, Catherine, Brabencova, Eva, Charafe-Jauffret, Emmanuelle, Chenard, Marie-Pierre, Dauplat, Marie-Mélanie, Delrée, Paul, Devouassoux, Mojgan, Fiche, Maryse, Fondrevelle, Marie-Eve, Fridman, Viviana, Garbar, Christian, Genin, Pascal, Ghnassia, Jean-Pierre, Haudebourg, Juliette, Laberge-Le Couteulx, Sophie, Loussouarn, Delphine, Maran-Gonzalez, Aurélie, Marcy, Myriam, Michenet, Patrick, Sagan, Christine, Trassard, Martine, Verriele, Véronique, Arnould, Laurent, and Lacroix-Triki, Magali

Published
2014
Full Text
View/download PDF

20. Renal cell carcinoma in children and adolescents: a retrospective study of a French–Italian series of 93 cases

Author

Denize, Thomas, primary, Massa, Simona, additional, Valent, Alexander, additional, Militti, Lucia, additional, Bertolotti, Alessia, additional, Barisella, Marta, additional, Rioux‐Leclercq, Nathalie, additional, Malouf, Gabriel G, additional, Spreafico, Filippo, additional, Verschuur, Arnauld, additional, van der Beek, Justine, additional, Tytgat, Lieve, additional, van den Heuvel‐Eibrink, Marry M, additional, Vujanic, Gordan, additional, Collini, Paola, additional, and Coulomb, Aurore, additional

Published
2022
Full Text
View/download PDF

22. An Immunosurveillance Mechanism Controls Cancer Cell Ploidy

Author

Senovilla, Laura, Vitale, Ilio, Martins, Isabelle, Tailler, Maximilien, Pailleret, Claire, Michaud, Mickaël, Galluzzi, Lorenzo, Adjemian, Sandy, Kepp, Oliver, Niso-Santano, Mireia, Shen, Shensi, Mariño, Guillermo, Criollo, Alfredo, Boilève, Alice, Job, Bastien, Ladoire, Sylvain, Ghiringhelli, François, Sistigu, Antonella, Yamazaki, Takahiro, Rello-Varona, Santiago, Locher, Clara, Poirier-Colame, Vichnou, Talbot, Monique, Valent, Alexander, Berardinelli, Francesco, Antoccia, Antonio, Ciccosanti, Fabiola, Fimia, Gian Maria, Piacentini, Mauro, Fueyo, Antonio, Messina, Nicole L., Li, Ming, Chan, Christopher J., Sigl, Verena, Pourcher, Guillaume, Ruckenstuhl, Christoph, Carmona-Gutierrez, Didac, Lazar, Vladimir, Penninger, Josef M., Madeo, Frank, López-Otín, Carlos, Smyth, Mark J., Zitvogel, Laurence, Castedo, Maria, and Kroemer, Guido

Published
2012
Full Text
View/download PDF

26. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S

Author

Bénard, Jean, Raguénez, Gilda, Kauffmann, Audrey, Valent, Alexander, Ripoche, Hugues, Joulin, Virginie, Job, Bastien, Danglot, Gisèle, Cantais, Sabrina, Robert, Thomas, Terrier-Lacombe, Marie-José, Chassevent, Agnès, Koscielny, Serge, Fischer, Matthias, Berthold, Frank, Lipinski, Marc, Tursz, Thomas, Dessen, Philippe, Lazar, Vladimir, and Valteau-Couanet, Dominique

Published
2008
Full Text
View/download PDF

27. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

Author

Ambros, Inge M., primary, Tonini, Gian-Paolo, additional, Pötschger, Ulrike, additional, Gross, Nicole, additional, Mosseri, Véronique, additional, Beiske, Klaus, additional, Berbegall, Ana P., additional, Bénard, Jean, additional, Bown, Nick, additional, Caron, Huib, additional, Combaret, Valérie, additional, Couturier, Jerome, additional, Defferrari, Raffaella, additional, Delattre, Olivier, additional, Jeison, Marta, additional, Kogner, Per, additional, Lunec, John, additional, Marques, Barbara, additional, Martinsson, Tommy, additional, Mazzocco, Katia, additional, Noguera, Rosa, additional, Schleiermacher, Gudrun, additional, Valent, Alexander, additional, Van Roy, Nadine, additional, Villamon, Eva, additional, Janousek, Dasa, additional, Pribill, Ingrid, additional, Glogova, Evgenia, additional, Attiyeh, Edward F., additional, Hogarty, Michael D., additional, Monclair, Tom F., additional, Holmes, Keith, additional, Valteau-Couanet, Dominique, additional, Castel, Victoria, additional, Tweddle, Deborah A., additional, Park, Julie R., additional, Cohn, Sue, additional, Ladenstein, Ruth, additional, Beck-Popovic, Maja, additional, De Bernardi, Bruno, additional, Michon, Jean, additional, Pearson, Andrew D. J., additional, and Ambros, Peter F., additional

Published
2020
Full Text
View/download PDF

28. List of contributors

Author

Diss, Tim, primary, Gray, Winifred, additional, Kardum-Skelin, Ika, additional, Kocjan, Gabrijela, additional, Levine, Tanya, additional, Marafioti, Teresa, additional, McGloin, John E., additional, Nolde, Nataša, additional, Tötsch, Martin, additional, Valent, Alexander, additional, and Vielh, Philippe, additional

Published
2013
Full Text
View/download PDF

31. DNA FISH Diagnostic Assay on Cytological Samples of Thyroid Follicular Neoplasms

Author

Vielh, Philippe, primary, Balogh, Zsofia, additional, Suciu, Voichita, additional, Richon, Catherine, additional, Job, Bastien, additional, Meurice, Guillaume, additional, Valent, Alexander, additional, Lacroix, Ludovic, additional, Marty, Virginie, additional, Motte, Nelly, additional, Dessen, Philippe, additional, Caillou, Bernard, additional, Ghuzlan, Abir, additional, Bidart, Jean-Michel, additional, Lazar, Vladimir, additional, Hofman, Paul, additional, Scoazec, Jean-Yves, additional, El-Naggar, Adel, additional, and Schlumberger, Martin, additional

Published
2020
Full Text
View/download PDF

35. Recommandations du GEFPICS pour la prise en charge des prélèvements dans le cadre du traitement néoadjuvant du cancer du sein

Author

Maran-Gonzalez, Aurélie, Franchet, Camille, Duprez-Paumier, Raphaelle, Antoine, Martine, Barlier, Catherine, Bécette, Véronique, Berghian, Anca, Blanc-Fournier, Cécile, Brabencova, Eva, Charafe-Jauffret, Emmanuelle, Chenard, Marie-Pierre, Dauplat, Marie-Mélanie, Delrée, Paul, Fleury, Clémence, Garbar, Christian, Ghnassia, Jean-Pierre, Haudebourg, Juliette, MacGrogan, Gaëtan, Mathieu, Marie-Christine, Michenet, Patrick, Penault-Llorca, Frédérique, Poulet, Bruno, Robin, Yves, Roger, Pascal, Russ, Elisabeth, Treilleux, Isabelle, Valent, Alexander, Verriele, Véronique, Vincent-Salomon, Anne, Arnould, Laurent, Lacroix-Triki, Magali, Institut du Cancer de Montpellier (ICM), Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Claudius Regaud, CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER, Hôpital René HUGUENIN (Saint-Cloud), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Unité de recherche interdisciplinaire pour la prévention et le traitement des cancers (ANTICIPE), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-UNICANCER-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Jean Godinot [Reims], Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital de Hautepierre [Strasbourg], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut de Pathologie et Génétique [Gosselies] (I.P.G.), Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509 (IRMAIC), Université de Reims Champagne-Ardenne (URCA), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Validation et identification de nouvelles cibles en oncologie (VINCO), Institut Bergonié [Bordeaux], UNICANCER-UNICANCER-Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de biologie et pathologie médicales [Gustave Roussy], Institut Gustave Roussy (IGR), Centre Hospitalier Régional d'Orléans (CHRO), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Université de Montpellier (UM), Département d'anatomopathologie, biopathologie, Centre Léon Bérard [Lyon], Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), Institut Curie [Paris], Université Lumière - Lyon 2 - UFR de Sciences économiques et de gestion (UL2 UFR SEG), Université Lumière - Lyon 2 (UL2), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service d'anatomie pathologique [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER, Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Lille Nord de France (COMUE)-UNICANCER, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CRLCC Institut Claudius Regaud, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Tenon [APHP], Institut de Cancérologie de Lorraine - Alexis Vautrin (ICL), Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN)-Centre Régional de Lutte contre le Cancer François Baclesse (CRLC François Baclesse ), Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Pathology Bratislava, NUT a RCH, Service d'Anatomie Pathologique Générale, CHU Strasbourg-Hôpital de Hautepierre [Strasbourg], Service d'anatomo-pathologie, Centre Jean Perrin, Pathology Department, CRLCC Paul Strauss, Laboratoire d'Anatomo-Pathologie, Hôpital Pasteur [Nice] (CHU), Université Bordeaux Segalen - Bordeaux 2-Institut Bergonié - CRLCC Bordeaux-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de pathologie, CHU Orléans, CRLCC Jean Perrin, Calculateurs Parallèles (CALCPAR), Institut de Recherche en Informatique et Systèmes Aléatoires (IRISA), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre National de la Recherche Scientifique (CNRS)-Université de Rennes 1 (UR1), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre National de la Recherche Scientifique (CNRS)-INRIA Rennes, Institut National de Recherche en Informatique et en Automatique (Inria), Institut de cancérologie de l'Ouest - Paul Papin (ICO - Paul Papin), Department of Tumor Biology, Institut Curie, and Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR)-Université Paris-Sud - Paris 11 (UP11)

Subjects
Neoplasm, Residual, Tissue sample, Recommandations, [SDV]Life Sciences [q-bio], Biopsy, Prélèvement, Breast Neoplasms, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Guidelines, Medical Records, Réponse pathologique, Specimen Handling, Breast cancer, Biomarkers, Tumor, Humans, Néoadjuvant, Breast, Cancer du sein, Microscopy, Sentinel Lymph Node Biopsy, Prognosis, Neoadjuvant Therapy, Tumor Burden, Treatment Outcome, Chemotherapy, Adjuvant, Female, France, Lymph Nodes, Drug Screening Assays, Antitumor, Pathological response
Abstract

International audience; Neoadjuvant therapy is an increasing treatment option in the management of breast cancer. The tumor response to neoadjuvant therapy, especially the pathological complete response, is a validated endpoint frequently used in clinical trials. However, there is still a lack of standardization for the surgical specimen management in the neoadjuvant setting. This leads to heterogeneity in the specimen handling and might lead to significant bias for the prognostic assessment of patients or in clinical trials. The GEFPICS group, composed of expert breast cancer pathologists, herein presents guidelines for the management of breast and axillary specimen before treatment (management of biopsy, items of the pathological report) and after neoadjuvant therapy (specimen handling, histological assessment of response, items of the pathological report and response grading systems).

Published
2018

38. Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological Insights

Author

Dumortier, Jérôme, primary, Dupuis‐Girod, Sophie, additional, Valette, Pierre‐Jean, additional, Valent, Alexander, additional, Guillaud, Olivier, additional, Saurin, Jean‐Christophe, additional, Hervieu, Valérie, additional, Robinson, Philip, additional, Plauchu, Henri, additional, Paliard, Pierre, additional, Boillot, Olivier, additional, and Scoazec, Jean‐Yves, additional

Published
2019
Full Text
View/download PDF

39. Various Genital and Reproductive Phenotypes in 46,XX/46,XY Chimeras

Author

Hercent, Agathe, primary, Amar, Edouard, additional, Valent, Alexander, additional, Belloc, Stéphanie, additional, Ferraretto, Xavier, additional, Hermieu, Jean-François, additional, Battin-Bertho, Régine, additional, Storey, Caroline, additional, Goubin-Versini, Isabelle, additional, Dijoud, Frédérique, additional, Tabet, Anne C., additional, Chantot-Bastaraud, Sandra, additional, Peycelon, Matthieu, additional, Morel, Hélène, additional, and Siffroi, Jean-Pierre, additional

Published
2019
Full Text
View/download PDF

40. Une nouvelle observation avec revue de la littérature

Author

Ngo, Carine, Khneisser, Pierre, Kanaan, Christina, Valent, Alexander, Dumont, Sarah, Adam, Julien, and Scoazec, Jean-Yves

Abstract

Le sarcome avec transcrit de fusion EWSR1-PATZ1est une entité très rare nouvellement décrite de sarcome « Ewing-like » impliquant EWSR1 mais pas les gènes de la famille ETS. La présentation clinique, morphologique et immunophénotypique des cas rapportés dans la littérature est variable et peu spécifique. Nous rapportons une nouvelle observation posant un réel défi diagnostique histologique et moléculaire.

Published
2021
Full Text
View/download PDF

42. Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients

Author

Rodriguez, Claudia, primary, Suciu, Voichita, additional, Poterie, Audrey, additional, Lacroix, Ludovic, additional, Miran, Isabelle, additional, Boichard, Amélie, additional, Delaloge, Suzette, additional, Deneuve, Jacqueline, additional, Azoulay, Sandy, additional, Mathieu, Marie-Christine, additional, Valent, Alexander, additional, Michiels, Stefan, additional, Arnedos, Monica, additional, and Vielh, Philippe, additional

Published
2016
Full Text
View/download PDF

44. Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study

Author

Massard, Christophe, primary, Oulhen, Marianne, additional, Le Moulec, Sylvestre, additional, Auger, Nathalie, additional, Foulon, Stéphanie, additional, Abou-Lovergne, Aurélie, additional, Billiot, Fanny, additional, Valent, Alexander, additional, Marty, Virginie, additional, Loriot, Yohann, additional, Fizazi, Karim, additional, Vielh, Philippe, additional, and Farace, Francoise, additional

Published
2016
Full Text
View/download PDF

45. Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, additional, Hero, Barbara, additional, Volland, Ruth, additional, Sterz, Carolina, additional, Schmidt, Rene, additional, Faldum, Andreas, additional, Kahlert, Yvonne, additional, Engesser, Anne, additional, Asgharzadeh, Shahab, additional, Seeger, Robert, additional, Ohira, Miki, additional, Nakagawara, Akira, additional, Scaruffi, Paola, additional, Tonini, Gian Paolo, additional, Janoueix-Lerosey, Isabelle, additional, Delattre, Olivier, additional, Schleiermacher, Gudrun, additional, Vandesompele, Jo, additional, Speleman, Frank, additional, Noguera, Rosa, additional, Piqueras, Marta, additional, Bénard, Jean, additional, Valent, Alexander, additional, Avigad, Smadar, additional, Yaniv, Isaac, additional, Grundy, Richard G., additional, Ortmann, Monika, additional, Shao, Chunxuan, additional, Schwab, Manfred, additional, Eils, Roland, additional, Simon, Thorsten, additional, Theissen, Jessica, additional, Berthold, Frank, additional, Westermann, Frank, additional, Brors, Benedikt, additional, and Fischer, Matthias, additional

Published
2015
Full Text
View/download PDF

46. Hommage à Alain Bernheim

Author

Dessen, Philippe, primary, Larsen, Christian-Jacques, additional, Valent, Alexander, additional, and Couturier, Jérôme, additional

Published
2014
Full Text
View/download PDF

48. Demystifying molecular techniques in cytopathology practice

Author

Fernando Schmitt, Longatto Filho, Adhemar, Valent, Alexander, Vielh, Philippe, and Universidade do Minho

Subjects
Cytopathology, FISH, Molecular biology, FNA
Abstract

The last decade was stimulating with the introduction of new molecular techniques to be applied in pathology laboratories. Accordingly, cytology was also benefited with the innovations emerged from this new era. Molecular cytopathology (MCP) can be defined as molecular studies applied on all types of cytological specimens, namely gynaecology cytology, exfoliative non-gyn cytology and fine needle aspirates. The development of a huge amount of new ancillary techniques has paralleled the emergence of clinical cytology as a major diagnostic speciality. Clinical applications of these techniques have been growing in the last decade. The widespread acceptance of liquid-based systems in gynaecological cytology is a paramount episode which re-draws the relation between cells and molecules. The stretched use of approaches, morphology and molecular biology, in HPV-induced lesions settings, e.g., revealed a potential to optimize, in one single brushed sample, diagnosis and research. Cytology samples from serous effusions, pulmonary tree, bladder urine, and aspirations, among others, are now likely to be studied by different molecular techniques for helping in diagnosis, prognosis, or even to assess therapeutic targets. In this review, we highlight the main results already published concerning the application of molecular techniques in different fields of cytopathology and discuss their application.

Published
2008

49. MET Genetic Abnormalities Unreliable for Patient Selection for Therapeutic Intervention in Oropharyngeal Squamous Cell Carcinoma

Author

Lacroix, Ludovic, primary, Post, Sophie F., additional, Valent, Alexander, additional, Melkane, Antoine E., additional, Vielh, Philippe, additional, Egile, Coumaran, additional, Castell, Christelle, additional, Larois, Christelle, additional, Micallef, Sandrine, additional, Saulnier, Patrick, additional, Goulaouic, Hélène, additional, Lefebvre, Anne-Marie, additional, and Temam, Stéphane, additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results